Vaccine Treatment for Surgically Resected Pancreatic Cancer

Clinical trial NCT00255827 · COMPLETED

Trial details

NCT number: NCT00255827
Sponsor: NewLink Genetics Corporation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2005-11-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.